Anxiety disorders are among the most prevalent pediatric behavioral health conditions, affecting roughly 32% of youths prior to adulthood, and associated with impaired functioning that can continue into adulthood and increase in severity.1,2 In this issue of JAMA Pediatrics, Wang et al3 report an updated meta-analysis evaluating the comparative efficacy of cognitive behavioral therapy (CBT) and pharmacotherapy for pediatric anxiety disorders. Results supported the efficacy of CBT, selective serotonin reuptake inhibitors (SSRIs), and their combination; limited support was provided for serotonin-norepinephrine reuptake inhibitors (SNRIs). We briefly review the evidence followed by implementation issues.
Asarnow JR, Rozenman MS, Carlson GA. Medication and Cognitive Behavioral Therapy for Pediatric Anxiety DisordersNo Need for Anxiety in Treating Anxiety. JAMA Pediatr. Published online August 31, 2017. doi:10.1001/jamapediatrics.2017.3017
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.